Merck and HAPPYneuron partner to include cognitive remediation program in Multiple Sclerosis e‑Health Solution

Mer­ck KGaA In Deal With HAP­PYneu­ron To Offer E‑Health Solu­tion For MS Patients (Nas­daq): “Ger­man drug mak­er Mer­ck KGaA (MKGAY.PK) announced Mon­day that it has entered into an agree­ment with HAP­PYneu­ron, a sub­sidiary of SBT Group of France, in which Mer­ck will receive an exclu­sive license to the com­pa­ny’s cog­ni­tive reme­di­a­tion train­ing pro­gram for people…

Read More